PhEur Reference Standards - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

PhEur Reference Standards

Most European Pharmacopoeia monographs refer to the use of reference standards (samples of thoroughly characterised substances, intended for use in the tests and assays described in the European Pharmacopoeia). The availability of these standards is essential for the application of the European Pharmacopoeia. The collection of reference standards used for the implementation of the European Pharmacopoeia now consists of more than 2500 substances or mixtures derived from chemical, biological or herbal origin. Their use extends far beyond the European continent. The online database contains over 2500 reference standards and is updated daily. Search by catalogue code, name, monograph or CAS number to find the standard you need. The EDQM also provides Batch Validity Statements, Safety Data Sheets and leaflets to download.

Download the Catalogue today at:

Search the PhEur Reference Standards Database:

EDQM, Council of Europe
Website: &

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
FindPharma Custom Search

Click here